Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026)
Celldex Therapeutics (CLDX) recorded quarterly EPS (Basic) of -$1.18 in Q1 2026, up 4.07% quarter-over-quarter from -$1.23 in Q4 2025, and down 45.68% on a YoY basis from -$2.17 in Q1 2025.
Celldex Therapeutics (CLDX) EPS (Basic) (2010 - 2026) Analysis & Trends
Celldex Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at -$1.18 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 45.68% year-over-year to -$1.18; the TTM figure through Mar 2026 stood at -$4.27 (down 58.15% YoY), while the FY2025 annual figure was -$3.9, down 59.18% from the prior year.
- EPS (Basic) was -$1.18 for Q1 2026 at Celldex Therapeutics, up from -$1.23 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.49 in Q1 2022 to a low of -$1.23 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.76 across 5 years, with a median of -$0.71 in 2024.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) sank 126.47% in 2022, then gained 20.99% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.57 in 2022, then sank by 47.37% to -$0.84 in 2023, then gained by 15.48% to -$0.71 in 2024, then sank by 73.24% to -$1.23 in 2025, then advanced by 4.07% to -$1.18 in 2026.
- The last three EPS (Basic) figures came in at -$1.18 (Q1 2026), -$1.23 (Q4 2025), and -$1.01 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Celldex Therapeutics | 2.16 Bn | 2.16 Bn | -1.44 Mn | -1.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.18 |
| Dec 31, 2025 | -1.23 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -0.85 |
| Mar 31, 2025 | -0.81 |
| Dec 31, 2024 | -0.71 |
| Sep 30, 2024 | -0.64 |
| Jun 30, 2024 | -0.54 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -0.84 |
| Sep 30, 2023 | -0.81 |
| Jun 30, 2023 | -0.65 |
| Mar 31, 2023 | -0.62 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -0.57 |
| Jun 30, 2022 | -0.77 |
| Mar 31, 2022 | -0.49 |
| Dec 31, 2021 | -0.43 |
| Sep 30, 2021 | -0.45 |
| Jun 30, 2021 | -0.34 |